Factors that influence experts’ use of warfarin. Importance was reported on a numeric analog scale, where 0 indicated not at all important and 10 extremely important.
| Factor (n = 38) | Mean Importance (SD) | Ranking* (95% CrI) | Probability of Having the Highest Ranking, % |
|---|---|---|---|
| NYHA/WHO functional class | 5.4 (2.5) | 2 (1, 3) | 46 |
| Age | 5.4 (2.3) | 2 (1, 3) | 36 |
| Degree of elevation of pulmonary artery pressure | 5.2 (2.5) | 2 (1, 3) | 18 |
| Peripheral vascular disease | 3.6 (2.7) | 4 (4, 5) | 0 |
| Pulmonary arterial hypertension disease duration | 2.8 (2.5) | 5 (5, 5) | 0 |
| Interstitial lung disease | 2.3 (2.1) | 6 (5, 7) | 0 |
| Sex | 1.7 (2.0) | 7 (6, 7) | 0 |
↵* Importance of factors affecting use of warfarin in patients with pulmonary arterial hypertension (1 = most important, 7 = least important). 95% CrI: 95% credible interval; NYHA/WHO: New York Heart Association/World Health Organization.